{"DataElement":{"publicId":"2188459","version":"1","preferredName":"Agent Megestrol Acetate Administered  Status","preferredDefinition":"administration status for the agent megestrol acetate.","longName":"AGT_MEGEST_ADM_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2762129","version":"1","preferredName":"Agent Megestrol Acetate Administered","preferredDefinition":"information related to the administration of megestrol acetate, the acetate salt form of megestrol, a synthetic derivative of the naturally occurring female sex hormone progesterone with anti-estrogenic activity and used in breast cancer treatment.","longName":"AGT_MEGES_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2762127","version":"1","preferredName":"Megestrol Acetate Administered","preferredDefinition":"The acetate salt form of megestrol, a synthetic derivative of the naturally occurring female sex hormone progesterone with anti-estrogenic activity and used in breast cancer treatment. Mimicking the action of progesterone, megestrol acetate binds to and activates nuclear progesterone receptors in the reproductive system, and causes the ligand-receptor complex to be translocated to the nucleus where it binds to and promotes expression of target genes. This leads to an alteration in protein synthesis, which modulates cell growth of reproductive tissues. Due to the negative feedback mechanism seen with progesterone, megestrol also blocks luteinizing hormone (LH) release from the pituitary gland, thereby leading to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. Furthermore, without stimulation of LH, estrogen release from the ovaries is stopped, hence impedes the growth of estrogen-sensitive tumor cells.:Given.","longName":"C1156:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Megestrol Acetate","conceptCode":"C1156","definition":"The acetate salt form of megestrol, a synthetic derivative of the naturally occurring female sex hormone progesterone with potential anti-estrogenic and antineoplastic activity. Mimicking the action of progesterone, megestrol acetate binds to and activates nuclear progesterone receptors in the reproductive system, and causes the ligand-receptor complex to be translocated to the nucleus where it binds to and promotes expression of target genes. This leads to an alteration in protein synthesis, which modulates cell growth of reproductive tissues. Due to the negative feedback mechanism seen with progesterone, megestrol also blocks luteinizing hormone (LH) release from the pituitary gland, thereby leading to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. Furthermore, without stimulation of LH, estrogen release from the ovaries is stopped, hence impedes the growth of estrogen-sensitive tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50FBCE4E-3185-74B7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-01","modifiedBy":"ONEDATA","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50FBCE4E-3196-74B7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188458","version":"1","preferredName":"Megestrol Acetate Agent Administered Status","preferredDefinition":"administration status for the agent megestrol acetate.","longName":"MEGESTR_AGT_ADM_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E44B4506-C622-2897-E034-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Not taken","valueDescription":"Not taken","ValueMeaning":{"publicId":"2571951","version":"1","preferredName":"Not taken","longName":"2571951","preferredDefinition":"Not taken","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E44B4506-C624-2897-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Initial","valueDescription":"Initial","ValueMeaning":{"publicId":"2567685","version":"1","preferredName":"Initial","longName":"2567685","preferredDefinition":"Preceding all others in time or space or degree.: A short textual account; having provided a short account.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Report","conceptCode":"C25375","definition":"A short textual account; having provided a short account.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D572-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"REEVESD","dateModified":"2014-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E44B4506-C626-2897-E034-0003BA3F9857","beginDate":"2003-12-31","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Second line","valueDescription":"Second line","ValueMeaning":{"publicId":"2571952","version":"1","preferredName":"Second line","longName":"2571952","preferredDefinition":"Second line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E44B4506-C628-2897-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Third line","valueDescription":"Third line","ValueMeaning":{"publicId":"2571954","version":"1","preferredName":"Third line","longName":"2571954","preferredDefinition":"Third line","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SHIDED","dateModified":"2004-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E44B4506-C62A-2897-E034-0003BA3F9857","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184340","version":"1","preferredName":"Status","preferredDefinition":"Status; a condition or state at a particular time.","longName":"Status","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20AD-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E449ADC7-A193-2854-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Megestrol Acetate","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E449FB4D-0D29-2899-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-17","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}